Lesinurad

Lesinurad

SCHEMBL29588047

O=C([O-])CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12.[Na+]

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC22A12

The experimentally established mechanism targets of Lesinurad. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SLC22A12 known ✓ Q96S37 20/20 0.81
CYP2C9 P11712 2/20 0.81
CYP2C19 P33261 2/20 0.81
CYP1A2 P05177 1/20 0.81
CYP3A4 P08684 1/20 0.81
CYP2D6 P10635 1/20 0.81
SLC22A11 Q9NSA0 1/20 0.81
SLC2A9 Q9NRM0 3/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lesinurad SCHEMBL1299308 1.00 SLC22A12 (0.81) SLC22A12CYP2C9CYP2C19CYP1A2CYP3A4
Lesinurad SCHEMBL2221210 0.99 SLC22A12 (0.79) SLC22A12CYP2C9CYP2C19CYP1A2CYP3A4
Lesinurad SCHEMBL1299973 0.98 SLC22A12 (0.81) SLC22A12CYP2C9CYP2C19CYP1A2CYP3A4
Lesinurad SCHEMBL842962 0.89 SLC22A12 (1.00) SLC22A12CYP2C9CYP2C19CYP1A2CYP3A4
Lesinurad SCHEMBL29353441 0.89 SLC22A12 (1.00) SLC22A12CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL4735350 0.88 SLC22A12 (0.82) SLC22A12CYP2C9CYP2C19CYP1A2CYP3A4
Lesinurad SCHEMBL2265513 0.88 SLC22A12 (0.98) SLC22A12CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL1299832 0.88 SLC22A12 (0.82) SLC22A12CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL16500465 0.88 SLC22A12 (0.82) SLC22A12CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL15698391 0.88 SLC22A12 (0.81) SLC22A12CYP2C9CYP2C19CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110790720-B Novel preparation method of febuxostat intermediate 内蒙古京东药业有限公司 2023-06-27 CN disclosed
US-20220160714-A1 METHODS FOR TREATING COLORECTAL CANCER ICAHN SCHOOL MED MOUNT SINAI (US) 2022-05-26 US disclosed